[1] 吴小艳, 王琳, 陈鸿博. 噬血细胞综合征研究进展[J]. 中华实用儿科临床杂志, 2020, 35(15):1125-1129. [2] CANNA SW, MARSH RA.Pediatric Hemophagocytic Lymphohistiocytosis[J]. Blood, 2020, 135(5):1332-1343. [3] 中华医学会感染病学分会艾滋病丙型肝炎学组中国疾病预防控制中心. 中国艾滋病诊疗指南(2021年版)[J]. 中国艾滋病性病,2021, 27(11):1182-1201. [4] 张碧波, 宋悦, 王昭. 围产期嗜血细胞综合征临床诊疗分析[J].中华血液学杂志, 2019,40(5):384-387. [5] 噬血细胞综合征中国专家联盟, 中华医学会儿科学分会血液学组. 噬血细胞综合征诊断与治疗指南(2022年版)[J]. 中华医学杂志, 2022, 102(20):1492-1499. [6] SCOTT RA.Histiocytic medullary reticulocytosis[J]. Lancet, 1939, 234:194-198. [7] 黄磊, 郭淑利, 肖蓬莉, 等. 成人原发性噬血细胞综合征合并EB病毒感染1例[J]. 内科, 2021, 19(11):964-965. [8] RAMOS-CASALS M, BRITO-ZERÓN P, LÓPEZ-GUILLERMO A, et al. Adult haemophagocytic syndrome[J]. Lancet, 2014, 383(7):1503-1516. [9] SUÁREZ-HORMIGA L, JAÉN-SÁNCHEZ MN, VERDUGO-ESPINOSA EA, et al. Hemophagocytic syndrome in patients infected with the human immunodeficiency virus: a study of 15 consecutive patients[J]. Rev Esp Quimioter, 2020, 33(5): 249-257. [10] CASTELLI AA, ROSENTHAL DG, BENDER IR, et al.Hemophagocytic lymphohistiocytosis secondary to human immunodeficiencv virus-associated histoplasmosis[J].Open Forum Infect Dis, 2015, 2(4):140-143. [11] MOSTAZA-FERNÁNDEZ JL, GUERRA LASO J, CARRIEDO ULE D, et al. Hemophagocytic lymphohistiocytosis associated with viral infections: Diagnostic challenges and therapeutic dilemas[J]. Rev Clin Esp, 2014, 214(16) :320-327. [12] ROUPHAEL NG, TALATI NJ, VAUGHAN C, et al.Infections associated with haemophagocytic syndrome[J]. Lancet Infect Dis, 2017, 7(15): 814-822. [13] LIU P, PAN X, CHEN C, et al.Nivolumab treatment of relapsed/refractory Epstein-Barr-virus-associated hemophagocytic lympho-histiocytosis in adults[J]. Blood, 2020, 135(11):826-833. [14] XU L.Serious consequences of Epstein-Barr virus infection: Hemophagocytic lymphohistocytosis[J]. Int J Lab Hematol, 2022, 16(2):78-80 [15] 杨智,吴伟刚,欧鹏程,等. 成人EBV感染临床特点及发生噬血细胞综合征的预测因素[J/CD].新发传染病电子杂志,2022,7(2):35-40. [16] AHN SS, YOO BW, JUNG SM, et al.Application of the 2016 EULAR/ACR/PRINTO classification criteria for macrophage activation syndrome in patients with adult-onset Still disease[J]. J Rheumatol, 2017, 44(7): 996-1003. [17] YAO SY.Epidemiological investigation of hemophagocytic lymphohistiocytosis in China[J].AIDS, 2021, 16(1):342-345. [18] TELLES JP, DE ANDRADE PM, MARCUSSO R, et al.Hemophagocytic syndrome in patients living with HIV: a retrospective study[J]. Ann Hematol,2019,98(1):67-72. [19] APODACA E, RODRÍGUEZ-RODRÍGUEZ S, TUNA-AGUILARE J, et al. Prognostic factors and out comes in adults with secondary hemophagocyti clymphohistiocytosis:a single center experience[J]. Clin Lymphoma Myeloma Leuk, 2018, 18(10): e373380. [20] BIRNDT S, SCHENK T, HEINEVETTER B, et al.Hemophagocytic lymphohistiocytosis in adults: collaborative analysis of 137 cases of a nationwide German registry[J]. J Cancer Res Clin Oncol, 2020, 146(4): 1065-1077. [21] YOON SE, EUN Y, HUH K, et al.A comprehensive analysis of adult patients with secondary hemophagocytic lymphohistiocytosis: a prospective cohort study[J]. Ann Hematol, 2020, 99(9): 2095-2104. [22] 周玉兰, 李菲, 张荣艳, 等.59例成人EB病毒相关噬血细胞综合征临床特点和预后分析[J]. 中国实验血液学杂志, 2020, 28(2):657-662. [23] SHAO XY.Epstein-Barr Virus-associated Hemophagocytic Lymphohistiocytosis in Adults: A Retrospective Analysis of 23 Patients in China[J]. Isr Med Assoc J, 2018, 20(2):80-85. |